Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Favorable regulatory scenario
3.2.1.2 Growing inclination towards planned delayed pregnancy
3.2.1.3 High unmet contraceptive needs
3.2.1.4 Growing prevalence of sexually transmitted diseases (STD)
3.2.2 Industry pitfalls & challenges
3.2.2.1 Growing infertility prevalence
3.2.2.2 Adverse effects of contraceptive drugs
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory scenario
3.6 Reimbursement scenario
3.7 Future market trends
3.8 Pricing analysis, 2023
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Drugs
5.2.1 Oral contraceptive pills
5.2.2 Injectable contraceptives
5.2.3 Topical contraceptives
5.3 Devices
5.3.1 Intra-uterine devices
5.3.1.1 Hormonal IUD
5.3.1.2 Copper IUD
5.3.2 Condoms
5.3.2.1 Male
5.3.2.2 Female
5.3.3 Subdermal implants
5.3.4 Vaginal rings
5.3.5 Diaphragms
5.3.6 Contraceptive sponges types
Chapter 6 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 15-44 years
6.3 Above 44 years
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Retail pharmacies
7.3 Hospital pharmacies
7.4 Online channels
7.5 Other distribution channels
Chapter 8 Market Estimates and Forecast, By Zone, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 East South Central
8.3 West South Central
8.4 South Atlantic
8.5 Mountain States
8.6 East North Central
8.7 Northeast
8.8 Pacific Central
8.9 West North Central
Chapter 9 Company Profiles
9.1 Allergan (AbbVie, Inc.)
9.2 Ani Pharmaceuticals
9.3 Bayer AG
9.4 CooperSurgical Inc
9.5 Church & Dwight Co, Inc.
9.6 Johnson & Johnson
9.7 Mayer Laboratories, Inc.
9.8 Merck & Co., Inc.
9.9 Meril Life Sciences Pvt. Ltd.
9.10 Perrigo Company
9.11 Pfizer, Inc.
9.12 Pregna International Ltd.
9.13 Reckitt Benckiser Group Plc.
9.14 Teva Pharmaceuticals Industries Ltd.
9.15 Veru Inc.
